ArticleAesthetic plastic surgery2026
Antifibrotic Agents for Silicone Implant Capsular Contracture: A Study on Nintedanib and Pirfenidone in Rats.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCapsular contracture is a frequent complication after breast implantation, often requiring revision surgery with high recurrence. Fibrosis and chronic inflammation are central to its pathogenesis; thus, antifibrotic pharmacological modulation is a promising preventive strategy. This study evaluated the effects of pirfenidone and nintedanib on capsular contracture in a rat model.
methodsTwenty-seven female Wistar albino rats were divided into control, pirfenidone, and nintedanib groups. Silicone block implants were placed under the panniculus carnosus. Pirfenidone (100 mg/kg/day) and nintedanib (50 mg/kg/day) were administered orally for eight weeks. At the end of the nine-week study period, the animals were euthanized, and the implants with the surrounding capsules were harvested for histological and immunohistochemical analyses. Capsular thickness and inflammatory cell counts were assessed histologically, while α-SMA expression and TGF-β expression were evaluated by immunohistochemistry. Collagen density and organization were examined using Masson's trichrome staining. Nonparametric tests were used for statistical analysis due to non-normal data distribution.
resultsBoth drugs significantly reduced capsular thickness, inflammatory cell infiltration, α-SMA, and TGF-β expression compared to control (p<0.001). Nintedanib showed significantly thinner capsules and lower α-SMA expression than pirfenidone (p<0.001), indicating stronger inhibition of fibrosis. Histological evaluation showed dense collagen fibers in the control group, while treatment groups had thinner, irregular collagen, most notably in the nintedanib group.
conclusionBoth agents significantly reduced fibrosis-related parameters compared with the control group. Compared with pirfenidone, nintedanib produced greater reductions in capsule thickness and α-SMA expression, whereas inflammatory cell counts and TGF-β expression were comparable between the two treatment groups. NO LEVEL ASSIGNED: This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
42736478What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.